May 2013

California’s Safer Consumer Products (SCP) regulations recently underwent the required economic impact analysis in order to complete the Economic and Fiscal Impact Statement (Notice File Number Z 2012-0717-04).

While the Security Exchange Commission and international regulatory bodies, such as the Organization for Economic Cooperative Development (OECD), have been uncharacteristic drivers of upstream supply chain compliance issues affecting the sourcing of medical device materials, public health regulatory agencies are deliberating over downstream concerns of “critical” medical device product shortages.